Leveraging the possibilities of modern science and advanced technologies, BioPhy is committed to transforming the way promising drugs are identified, developed, and tested.
With the help of our patent-pending predictive AI engine BioLogic, and our generative AI solution BioPhyRx, we work to enhance the outcomes of clinical trials, reduce failure and non-compliance rates, accelerate the pace of developing new drugs, and moreover, improve the quality of healthcare outcomes across the globe.
Meet the founders:
Dave Latshaw II, Ph.D.: https://www.linkedin.com/in/davidlatshawii/
Steve Truong: https://www.linkedin.com/in/stevenhtruong1
Daniel Sciubba, MD: https://www.linkedin.com/in/daniel-sciubba-md-wharton-mba-cand
BioPhy is a Philadelphia-based, venture backed company. Contact us at info@biophy.ai